Earlier quoted context omitted.
And when we're discussing medical care, the mandatory regulatory approvals are a significant cause of delay and cost. E.g. FDA approvals in the U.S. They are a barrier to entry, and they are a measure to ensure safety of new cures. It's a tough balance.
Based on the history of drugs like Thalidomide, I'll pick safety. https://en.wikipedia.org/wiki/Thalidomide#History
It seems to me that the safety aspect is currently very strong, on the expense of long time-to-market and high barrier of entry to market.